MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Author(s) -
Steven P. Treon,
Lian Xu,
Guang Yang,
Yangsheng Zhou,
Xia Liu,
Yang Cao,
Patricia Sheehy,
Robert Manning,
Christopher J. Patterson,
Christina Tripsas,
Luca Arcaini,
Geraldine S. Pinkus,
Scott J. Rodig,
Aliyah R. Sohani,
Nancy L. Harris,
Jason M. Laramie,
Donald A. Skifter,
Stephen E. Lincoln,
Zachary R. Hunter
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1200710
Subject(s) - waldenstrom macroglobulinemia , macroglobulinemia , lymphoplasmacytic lymphoma , medicine , gammopathy , immunoglobulin m , sanger sequencing , bone marrow , multiple myeloma , germline mutation , marginal zone b cell lymphoma , pathology , lymphoma , cancer research , immunology , marginal zone , monoclonal , mutation , b cell , biology , antibody , immunoglobulin g , genetics , monoclonal antibody , gene
Waldenström's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom